Currency
Get Your BitCoins at COINBASE
Friday, July 1, 2016
AstraZeneca Ends European Licensing Pact With Valeant
The British pharmaceutical giant says the Canadian drugmaker will continue to lead development and marketing of psoriasis drug brodalumab in the U.S.
from WSJ.com: US Business http://ift.tt/297q4qz
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment